Form 8-K - Current report:
SEC Accession No. 0001999371-24-000837
Filing Date
2024-01-25
Accepted
2024-01-25 16:08:08
Documents
18
Period of Report
2024-01-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_012524.htm   iXBRL 8-K 42895
2 CERTIFICATE OF AMENDMENT TO TONIX PHARMACEUTICALS HOLDING CORP. ex3-01.htm EX-3.(01) 4945
6 GRAPHIC ex3-01_img1.jpg GRAPHIC 342463
7 GRAPHIC ex3-01_img2.jpg GRAPHIC 312814
8 GRAPHIC ex3-01_img3.jpg GRAPHIC 577684
9 GRAPHIC ex3-01_img4.jpg GRAPHIC 490434
10 GRAPHIC ex3-01_img5.jpg GRAPHIC 226089
  Complete submission text file 0001999371-24-000837.txt   2906647

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20240125.xsd EX-101.SCH 2991
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20240125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20240125_pre.xml EX-101.PRE 22343
12 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_012524_htm.xml XML 3296
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24562221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)